Translational vision science & technology · 2025
The Association of Social Determinants of Health on Monitoring for Disease Progression Among Patients With Primary Open-Angle Glaucoma.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kanwar Kunal, Ramachandran Rithambara, Stein Joshua D, Andrews Chris A, Chaudhury Azraa S, Ige Maryam, Zhou Xueqing, Marwah Shikha, Li Yang, Evans Charlesnika T, Kho Abel N, Bryar Paul J, French Dustin D, Sight Outcomes Research Collaborative (SOURCE) Consortium
Аннотация
PURPOSE: To examine the association of race, ethnicity, and other social determinants of health (SDH) on receipt of optic nerve (ON) evaluation in accordance with National Quality Forum (NQF) and the American Academy of Ophthalmology (AAO) guideline-based metrics.
METHODS: This was a retrospective cohort study consisting of 13,582 patients with POAG receiving care across 12 tertiary care health. The odds of receiving ≥1 ON evaluations to monitor for glaucoma progression over 45 months of follow-up was evaluated.
RESULTS: White patients (61%) with primary open angle glaucoma (POAG) had more guideline recommended ON evaluations during the 45-month follow-up period, compared with Asian American (52%) and Black (53%) patients (P < 0.001 for both). More non-Hispanic patients with POAG (58%) had ON evaluations in all 3 time periods compared with persons of Latinx ethnicity (52%) (P = 0.045). The odds of undergoing ON evaluations were 17% lower for Black patients compared with White patients (odds ratio [OR] = 0.83; confidence interval [CI], 0.74-0.94), 56% lower for patients living in isolated rural communities (OR = 0.44; CI, 0.25-0.77) compared to urban areas, and 9% lower for patients residing in more impoverished communities (OR = 0.91; CI, 0.86-0.96).
CONCLUSIONS: Racial and ethnic minorities and those residing in lesser affluent or rural communities are less likely to receive monitoring for POAG progression in accordance with NQF and AAO guidelines.
TRANSLATIONAL RELEVANCE: This study aimed to determine the association between SDH and receiving POAG testing according to clinical practice guidelines, with a goal of identifying factors contributing to disparities in care. This should facilitate development of targeted clinical interventions for vulnerable patients with POAG while factoring technology, economic sustainability, and policy.
METHODS: This was a retrospective cohort study consisting of 13,582 patients with POAG receiving care across 12 tertiary care health. The odds of receiving ≥1 ON evaluations to monitor for glaucoma progression over 45 months of follow-up was evaluated.
RESULTS: White patients (61%) with primary open angle glaucoma (POAG) had more guideline recommended ON evaluations during the 45-month follow-up period, compared with Asian American (52%) and Black (53%) patients (P < 0.001 for both). More non-Hispanic patients with POAG (58%) had ON evaluations in all 3 time periods compared with persons of Latinx ethnicity (52%) (P = 0.045). The odds of undergoing ON evaluations were 17% lower for Black patients compared with White patients (odds ratio [OR] = 0.83; confidence interval [CI], 0.74-0.94), 56% lower for patients living in isolated rural communities (OR = 0.44; CI, 0.25-0.77) compared to urban areas, and 9% lower for patients residing in more impoverished communities (OR = 0.91; CI, 0.86-0.96).
CONCLUSIONS: Racial and ethnic minorities and those residing in lesser affluent or rural communities are less likely to receive monitoring for POAG progression in accordance with NQF and AAO guidelines.
TRANSLATIONAL RELEVANCE: This study aimed to determine the association between SDH and receiving POAG testing according to clinical practice guidelines, with a goal of identifying factors contributing to disparities in care. This should facilitate development of targeted clinical interventions for vulnerable patients with POAG while factoring technology, economic sustainability, and policy.